|
|
|
The predictive value of metabolic syndrome in the evaluation of pregnancy course and outcome |
M. Trisovic1, 2, *( ), O. Mladenovic3, J. Bila4, K. Lalić5, D. Kisic Tepavcevic6 |
1Hospital for Gynecology and Obstetrics, University Center zvezdara, Belgrade, Serbia 2High Health School of Professional Studies, University of Belgrade, Belgrade, Serbia 3Sports Academy, University of Belgrade, Belgrade, Serbia 4Department for Gynecology and Obstetrics, Clinical Center of Serbia; School of Medicine, University of Belgrad, Belgrade, Serbia 5Department for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia; School of Medicine, University of Belgrade, Belgrade, Serbia 6Institute for Epidemiology, School of Medicine, University of Belgrade, Belgrade, Serbia |
|
|
Abstract Aim: Determining the prevalence of metabolic syndrome (MS) in the tested sample of pregnant women in the second and third trimesters of pregnancy, as well as the prognostic significance of MS in assessing the course and outcome of pregnancy. Materials and Methods: Prospective cohort study included 135 pregnant women after 24 0/7 weeks of pregnancy, hospitalized in the period from the January 1st, 2014 until September 30th, 2014. Data analysis included descriptive and analytical methods. Results: After assessment of possible confounding effect of age the authors confirmed that women with MS were 1,685-fold more likely give birth by caesarean section (OR = 1.685, p = 0.048), that it was a statistically significant prognostic factor in the earlier weeks of delivery (p = 0.001), and that it was statistically significant prognostic factor of lower Apgar scores in infants (p = 0.003). Conclusion: The early detection of MS during pregnancy reduces perinatal morbidity and is an important factor for the pregnancy outcome.
|
Published: 10 October 2019
|
*Corresponding Author(s):
M. TRISOVIC
E-mail: m.trisovic@gmail.com
|
[1] |
Eli M. Roth, Michael H. Davidson. PCSK9 Inhibitors: Mechanism of Action, Efficacy, and Safety[J]. Reviews in Cardiovascular Medicine, 2018, 19(S1): 31
-46
. |
[2] |
Sandeep K. Krishnan, Norman E. Lepor. Acute and Chronic Cardiovascular Effects of Hyperkalemia: New Insights Into Prevention and Clinical Management[J]. Reviews in Cardiovascular Medicine, 2016, 17(S1): 9
-21
. |
[3] |
Ibrahim Sidiqi, Patrick Alexander. Current Advances in Endovascular Therapy for Infrapopliteal Artery Disease[J]. Reviews in Cardiovascular Medicine, 2015, 16(1): 36
-50
. |
[4] |
Peter Shalit. Management of Dyslipidemia in Patients With Human Immunodeficiency Virus[J]. Reviews in Cardiovascular Medicine, 2014, 15(S1): 38
-46
. |
[5] |
Sophie Mavrogeni, Fabrizio Cantini, Gerald M. Pohost. Systemic Vasculitis: An Underestimated Cause of Heart Failure—Assessment by Cardiovascular Magnetic Resonance[J]. Reviews in Cardiovascular Medicine, 2013, 14(1): 49
-55
. |
[6] |
George L. Smith. Appropriate Use Criteria: The Gold Standard, or a Mechanism for the Derogation of Clinical Judgment?[J]. Reviews in Cardiovascular Medicine, 2011, 12(2): 105
. |
[7] |
Prabhjot Singh Nijjar, Anoop Parameswaran, Aman M. Amanullah. Evaluation of Anomalous Aortic Origins of the Coronaries by 64-Slice Cardiac Computed Tomography[J]. Reviews in Cardiovascular Medicine, 2007, 8(3): 175
-181
. |
[8] |
. SELF-ASSESSMENT POST-TEST[J]. Reviews in Cardiovascular Medicine, 2006, 7(S2): 51
-52
. |
[9] |
Alice K. Jacobs. Gender Differences in Coronary Revascularization: Does Age Make a Difference?[J]. Reviews in Cardiovascular Medicine, 2004, 5(1): 68
-70
. |
[10] |
Jeffrey W. Moses, Stephane Carlier, Issam Moussa. Lesion Preparation Prior to Stenting[J]. Reviews in Cardiovascular Medicine, 2004, 5(S2): 16
-21
. |
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|